Literature DB >> 12527926

Stage-specific expression of Clast6/E3/LAPTM5 during B cell differentiation: elevated expression in human B lymphomas.

Mika Seimiya1, Jiyang O-Wang, Rumana Bahar, Kiyoko Kawamura, Yanqing Wang, Hiromitsu Saisho, Masatoshi Tagawa.   

Abstract

We have identified a CD40-regulated gene, Clast6/E3/LAPTM5, by subtraction of cDNAs derived from resting and CD40 ligand-treated B cells. Clast6/E3/LAPTM5 is abundantly expressed in resting mature B cells but is rapidly and transiently repressed by treatment with CD40 ligand, a T helper signal that induces B cell activation. Using a fluorescence activated cell sorter, we have purified B-lineage cells into distinct populations based on their differential expression of cell surface markers. Clast6/E3/LAPTM5 was found to be highly expressed in progenitor and precursor B cells, downregulated in late pre-B and immature B cells, and upregulated again in mature B and the germinal center B cells. Interestingly, Clast6/E3/LAPTM5 was expressed at high levels in malignant B lymphomas. These results reveal stage-specific expression of Clast6/E3/LAPTM5 during B cell differentiation and implicates its possible involvement in B cell malignancies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527926

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages.

Authors:  Wioletta K Glowacka; Philipp Alberts; Rika Ouchida; Ji-Yang Wang; Daniela Rotin
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

2.  LAPTM5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway.

Authors:  Ying Wang; Jun Liu; Chizuru Akatsu; Runyun Zhang; Hai Zhang; Han Zhu; Kangwei Liu; Han-Ying Zhu; Qing Min; Xin Meng; Chaoqun Cui; Yue Tang; Meiping Yu; Yaxuan Li; Xiaoqian Feng; Hao Wei; Zichao Wen; Sihan Ji; Martin G Weigert; Takeshi Tsubata; Ji-Yang Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779

3.  The genomic and transcriptional landscape of primary central nervous system lymphoma.

Authors:  Josefine Radke; Naveed Ishaque; Randi Koll; Zuguang Gu; Elisa Schumann; Lina Sieverling; Sebastian Uhrig; Daniel Hübschmann; Umut H Toprak; Cristina López; Xavier Pastor Hostench; Simone Borgoni; Dilafruz Juraeva; Fabienne Pritsch; Nagarajan Paramasivam; Gnana Prakash Balasubramanian; Matthias Schlesner; Shashwat Sahay; Marc Weniger; Debora Pehl; Helena Radbruch; Anja Osterloh; Agnieszka Korfel; Martin Misch; Julia Onken; Katharina Faust; Peter Vajkoczy; Dag Moskopp; Yawen Wang; Andreas Jödicke; Lorenz Trümper; Ioannis Anagnostopoulos; Dido Lenze; Ralf Küppers; Michael Hummel; Clemens A Schmitt; Otmar D Wiestler; Stephan Wolf; Andreas Unterberg; Roland Eils; Christel Herold-Mende; Benedikt Brors; Reiner Siebert; Stefan Wiemann; Frank L Heppner
Journal:  Nat Commun       Date:  2022-05-10       Impact factor: 17.694

4.  Functional proteomics mapping of a human signaling pathway.

Authors:  Frédéric Colland; Xavier Jacq; Virginie Trouplin; Christelle Mougin; Caroline Groizeleau; Alexandre Hamburger; Alain Meil; Jérôme Wojcik; Pierre Legrain; Jean-Michel Gauthier
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

5.  Gene expression profiles in Finnish twins with multiple sclerosis.

Authors:  Silja Särkijärvi; Hanna Kuusisto; Raija Paalavuo; Mari Levula; Nina Airla; Terho Lehtimäki; Jaakko Kaprio; Markku Koskenvuo; Irina Elovaara
Journal:  BMC Med Genet       Date:  2006-02-27       Impact factor: 2.103

6.  TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer.

Authors:  Hideaki Umeyama; Mitsuo Iwadate; Y-h Taguchi
Journal:  BMC Genomics       Date:  2014-12-08       Impact factor: 3.969

7.  Induction of Lysosome-associated Protein Transmembrane 4 Beta via Sulfatase 2 Enhances Autophagic Flux in Liver Cancer Cells.

Authors:  Yeonjung Ha; Yong Fang; Paola A Romecin Duran; Ezequiel J Tolosa; Catherine D Moser; Martin E Fernandez-Zapico; Lewis R Roberts
Journal:  Hepatol Commun       Date:  2019-09-25

Review 8.  Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments.

Authors:  David C Soler; Amber Kerstetter-Fogle; Thomas S McCormick; Andrew E Sloan
Journal:  J Neurooncol       Date:  2021-11-26       Impact factor: 4.130

9.  Key Prognostic Value of Lysosomal Protein Transmembrane 5 in Kidney Renal Clear Cell Carcinoma.

Authors:  Bin Li; Xue-Dong Shi
Journal:  Int J Gen Med       Date:  2022-03-05

10.  AAMP is a binding partner of costimulatory human B7-H3.

Authors:  Sara Ciprut; Anne Berberich; Maximilian Knoll; Stefan Pusch; Dirk Hoffmann; Jennifer Furkel; Aoife Ward Gahlawat; Lena Kahlert-Konzelamnn; Felix Sahm; Uwe Warnken; Martin Winter; Martina Schnölzer; Sonja Pusch; Andreas von Deimling; Amir Abdollahi; Wolfgang Wick; Dieter Lemke
Journal:  Neurooncol Adv       Date:  2022-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.